Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived Stem Cells for Diabetic Foot
NCT03916211Phase 1Unknown
- Start
- Apr 2019
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised, triple-blind trial of autologous adipose-derived mesenchymal stromal cells in diabetic foot ulcer (DFU) (2 arms). Primary endpoints: Ulcer healing rate at 4 weeks and Amputation rate at 4 weeks. Status: unknown.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03916211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03916211.